Navigation Tip: Click on blue text that’s underlined and in bold for link to more information.
PLEASE NOTE: For those that subscribe to receive a hard copy of the Hot SHEET newsletter, we will not be sending out physical copies due to Illinois' shelter in place policy related to the coronavirus. We apologize, but we cannot safely gather in order to distribute the physical copies at this time. We appreciate your understanding. The digital version, of the June issue, however, is available here...
Dear Reader,
June is Men’s Health Month
Did you know?:
“On average, men die five years younger than women, and die at higher rates from nine of the top 10 causes of death.” While you’re protecting yourself, and the men in your life, from COVID-19 and prostate cancer, please manage all aspects of your health: physical, mental, environmental, and more. The federal government offers a great deal of well-researched advice at
https://bit.ly/309drV1
and
www.minorityhealth.hhs.gov/omh/content.aspx?ID=10238S
.
SEA Blue 2020 Goes National and Virtual/Live on September 13th
Join us September 13, 2020 as the SEA Blue Prostate Cancer Walk/Run goes virtual! As with the ever-changing times, we will continue to bring you an amazing event while raising awareness about prostate cancer on a national level! You will be able to participate from the comfort of your own hometown while joining us virtually through LIVE streaming and video. Look for more information regarding registering for this amazing one-day event and how you can bring SEA Blue to your area!
“The Talk” Webinar
Join AnCan and Us TOO for a conversation on how and if men with prostate cancer should talk to their kids about why it could impact their lives. This free webinar takes place on Tuesday, June 30, 2020 at 8:00pm (EDT). This is the first in our series of three
Prostate Cancer Connections
webinars. For more information or to register, please visit
www.ustoo.org/pdfs/AnCan_UsTOO_Webcast_Brochure.pdf
.
This month’s
Hot SHEET
contains a diverse group of articles dealing with prostate cancer and its impact. These include:
Time to Reassess Active Surveillance Risks in Prostate Cancer?
The ProtecT trial suggests a small survival edge for upfront treatment compared to active surveillance. Patients may wish to discuss such information with their care teams when making the very personal choice among treatment options.
Too Much Radiotherapy Still Being Used for Bone Metastases
This article reports that only 9% of patients with bone metastases are receiving the recommended, single-fraction radiotherapy treatment. That treatment has been strongly recommended since 2013.
“Intrusive Thought Awareness During a Pandemic?!”
This column by Dr. Mark A. Moyad discusses specific connections between prostate cancer and mental health. His ongoing perspectives on COVID-19 and prostate cancer are collected at
www.ustoo.org/covid
.
Radical Prostatectomy Without Pelvic Lymph Node Dissection is Widely Practiced in High-Risk Patients Despite Poorer Survival
This article finds that radical prostatectomy
without
pelvic lymph node dissection is widely practiced even though
pelvic lymph node dissection is the standard of care
for patients with unfavorable-risk prostate cancer.
Thank you for all you do in the work against prostate cancer.
Shalom. Salaam. Peace.
